MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

TG Therapeutics' financial health is solid, with a market cap of $5.7bn and a strong cash position, ensuring an indefinite ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Ocrevus treatment was linked to increases in myelin and reductions in iron in MS patients with paramagnetic rim lesions, per ...

Natural treatments for multiple sclerosis can play a role in managing MS symptoms and possibly slowing the advance of the condition. Options include diet, exercise, and stress management strategies.

Higher ocrelizumab doses improve the benefit-risk profile among patients with relapsing multiple sclerosis treated with it for up to 10 years.

Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.

Drug group or drug name Drug examples What can happen alemtuzumab (Campath, Lemtrada) — can increase the risk of immunosuppression as a side effect of Copaxone and alemtuzumab ocrelizumab ...